Azurity Pharmaceuticals Acquires Slayback Pharma
09/27/23, 12:34 PM
Location
Industry
pharmaceutical
medical
biotechnology
health care
manufacturing
Azurity Pharmaceuticals, Inc. ("Azurity") is pleased to announce the closing of its acquisition of Slayback Pharma LLC ("Slayback") today from existing investors including KKR, a leading global investment firm, and Everstone Capital. Slayback is now a wholly-owned subsidiary of Azurity.
Company Info
Location
Woburn, Massachusetts, United States
Company info
Azurity is a privately-held pharmaceutical company specializing in providing innovative, high-quality medicines that serve overlooked patients. Azurity supplies a large number of products to treat a wide range of medical conditions. These include cardiovascular, central nervous system, endocrine, gastro-intestinal, anti-infective and oncology medicines. Many of Azurity's medicines are dose-form innovations for patients with needs that are not met by other available products. Azurity's medicines have benefited millions of people.
Related People

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Rh
Rh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Ah
Ah • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more